Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Kit
NDC Package 68462-849-29
Package Information
Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate kits is norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules are indicated for use by females of reproductive age to prevent pregnancy [see Clinical Studies (14)].The efficacy of norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules in women with a body mass index (BMI) of more than 35 kg/m2 has not been evaluated. This formulation utilizes a kit delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-849 and is authorized under FDA application ANDA213418.
Identification & Billing
- RxCUI: 1421459 - ethinyl estradiol 20 MCG / norethindrone acetate 1 MG Oral Capsule
- RxCUI: 1421459 - ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule
- RxCUI: 1421460 - ferrous fumarate 75 MG Oral Capsule
- RxCUI: 1421461 - {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack
- RxCUI: 1421461 - Eth estra-Noreth Ac 0.02-1 MG (24) Oral Capsule / Ferr fum 75 MG (4) Oral Capsule 28 Day Pack
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68462 - Glenmark Pharmaceuticals Inc., Usa
- 68462-849 - Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate
- 68462-849-29 - 3 CARTON in 1 BOX / 1 BLISTER PACK in 1 CARTON (68462-849-84) / 1 KIT in 1 BLISTER PACK * 24 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (68462-821-40) * 4 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (68462-822-40)
- 68462-849 - Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68462-849-29 identifies a specific commercial package of 3 carton in 1 box / 1 blister pack in 1 carton (68462-849-84) / 1 kit in 1 blister pack * 24 capsule, liquid filled in 1 blister pack (68462-821-40) * 4 capsule, liquid filled in 1 blister pack (68462-822-40) of Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on July 27, 2022. The current certification is valid through December 31, 2027.
How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462084929. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.